Back to UBS Group AG UBS Group AG

AMPHAMPH
30 quarters

Position history for UBS Group AGUBS Group AG's holdings in AMPHASTAR PHARMACEUTICALS IN

UBS Group AG holds 393,110 shares of AMPH (AMPHASTAR PHARMACEUTICALS IN), worth $7.9M as of 2026-Q2. The position was decreased (-6.5% shares). AMPH represents 0.0% of UBS Group AG's portfolio.

Current Value

$7.9M

Current Shares

393,110

Total Value Change

+$7.1M

Total Shares Change

+350,384

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
393,110
-6.5%
$7.9M0.0%$20.18
0
2026-Q1
Increased
420,263
+63.8%
$8.2M0.0%$19.83
40
2025-Q4
Decreased
256,624
-17.8%
$6.9M0.0%$27.00
0
2025-Q3
Increased
312,274
+367.2%
$8.3M0.0%$26.92
44
2025-Q2
Decreased
66,834
-25.2%
$1.5M0.0%$23.08
0
2025-Q1
Decreased
89,324
-41.9%
$2.6M0.0%$28.43
0
2024-Q4
Increased
153,742
+52.2%
$5.7M0.0%$36.84
38
2024-Q3
Decreased
101,032
-17.6%
$4.9M0.0%$48.02
0
2024-Q2
Increased
122,681
+52.5%
$4.9M0.0%$40.00
38
2024-Q1
Increased
80,452
+13.2%
$3.5M0.0%$43.91
30
2023-Q4
Increased
71,086
+286.9%
$4.4M0.0%$61.85
43
2023-Q3
Increased
18,372
+23.7%
$844,9290.0%$45.99
30
2023-Q2
Decreased
14,848
-35.4%
$853,3150.0%$55.91
0
2023-Q1
Increased
22,990
+34.6%
$862,1260.0%$37.67
32
2022-Q4
Increased
17,074
+10.5%
$478,4140.0%$28.02
27
2022-Q3
Decreased
15,450
-43.9%
$434,0000.0%$28.99
0
2022-Q2
Decreased
27,536
-1.3%
$958,0000.0%$34.15
0
2022-Q1
Increased
27,889
+107.8%
$1M0.0%$36.43
40
2021-Q4
Increased
13,418
+44.9%
$313,0000.0%$23.14
32
2021-Q3
Decreased
9,260
-70.0%
$176,0000.0%$19.21
0
2021-Q2
Decreased
30,887
-26.4%
$623,0000.0%$20.29
0
2021-Q1
Decreased
41,943
-2.4%
$769,0000.0%$18.00
0
2020-Q4
Increased
42,981
+152.1%
$865,0000.0%$19.85
40
2020-Q3
Decreased
17,051
-52.0%
$320,0000.0%$18.63
0
2020-Q2
Increased
35,542
+15.1%
$798,0000.0%$22.12
28
2020-Q1
Decreased
30,879
-52.8%
$458,0000.0%$15.12
0
2019-Q4
Increased
65,464
+3.1%
$1.3M0.0%$19.22
26
2019-Q3
Increased
63,468
+20.1%
$1.3M0.0%$20.22
30
2019-Q2
Increased
52,836
+23.7%
$1.1M0.0%$21.11
31
2019-Q1
New
42,726
-
$873,0000.0%$20.43
34

Other major holders of AMPH: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used